Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ImmuCell Corporation
ICCCCurrent price
5.50 USD
-0.05 USD (-0.90%)
Last closed
5.38 USD
Company
immucell.com
ISIN
US4525253062
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
49 404 408 USD
Yield for 12 month
+9.34 %
1Y
3Y
5Y
10Y
15Y
ICCC
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine. Address: 56 Evergreen Drive, Portland, ME, United States, 04103
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
14.00 USDP/E ratio
–Dividend Yield
–Current Year
+26 493 169 USD
Last Year
+17 471 669 USD
Current Quarter
+7 751 000 USD
Last Quarter
+6 011 573 USD
Current Year
+7 941 044 USD
Last Year
+4 396 284 USD
Current Quarter
+2 832 000 USD
Last Quarter
+1 583 554 USD
Key Figures ICCC
1 year
3 years
5 years
10 years
EBITDA
1 454 022 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-1.73 %
PEG Ratio
–
Return On Equity TTM
-8.21 %
Wall Street Target Price
14.00 USD
Revenue TTM
26 493 168 USD
Book Value
3.07 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
52.10 %
Dividend Yield
–
Gross Profit TTM
8 348 044 USD
Earnings per share
-0.26 USD
Diluted Eps TTM
-0.26 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
-63.40 %
Profit Margin
-8.14 %
Dividend Analytics ICCC
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ICCC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
25.07.1990
Stock Valuation ICCC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.29
Price Sales TTM
1.86
Enterprise Value EBITDA
56.87
Price Book MRQ
1.79
Financials ICCC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ICCC
For 52 weeks
3.34 USD
5.82 USD
50 Day MA
5.10 USD
Shares Short Prior Month
13 234
200 Day MA
4.37 USD
Short Ratio
1.23
Shares Short
13 161
Short Percent
0.18 %
BeatStart